

Other version: https://www.sciencedirect.com/science/article/abs/pii/S1552526019300846
![]() |
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype |
|
Authors | ![]() | |
Collaboration | With : Zekry Berger, Dina Selma | |
Published in | Alzheimer's & Dementia. 2019, vol. 15, no. 7, p. 888-898 | |
Abstract | We estimated the age-specific duration of the preclinical, prodromal, and dementia stages of Alzheimer's disease (AD) and the influence of sex, setting, apolipoprotein E (APOE) genotype, and cerebrospinal fluid tau on disease duration. | |
Keywords | Aged — Alleles — Alzheimer Disease/genetics/pathology — Amyloid — Apolipoprotein E4/genetics — Biomarkers/cerebrospinal fluid — Cognitive Dysfunction/pathology — Disease Progression — Female — Genotype — Humans — Longitudinal Studies — Male — Positron-Emission Tomography — Prodromal Symptoms — Sex Factors — Time Factors — tau Proteins/cerebrospinal fluid | |
Identifiers | PMID: 31164314 | |
Full text |
![]() ![]() Other version: https://www.sciencedirect.com/science/article/abs/pii/S1552526019300846 |
|
Structures | ||
Citation (ISO format) | VERMUNT, Lisa et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. In: Alzheimer's & Dementia, 2019, vol. 15, n° 7, p. 888-898. doi: 10.1016/j.jalz.2019.04.001 https://archive-ouverte.unige.ch/unige:146823 |